Delivery Order SPE2DB20D1110-SPE2DB24FK41M
Award Date
7/29/24
Potential Completion Date
7/30/24
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,710.75 Delivery Order contract is for the supply of the prescription medication GRALISE ER 600 MG TABLETS in quantities of 90. The contract has a firm fixed price and an ultimate completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00...
This federal contract award, valued at $1,873.20, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, with a performance period through March 13, 2024. This contract award does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken,...
This federal contract award, valued at $2,317.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GRALISE ER 300 MG TABLET 90S, a prescription medication, and has an ultimate completion date of December 9, 2024. This contract is a delivery order, with a firm fixed-price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp, a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.67 firm fixed-price delivery order is for the supply of GRALISE ER 600 MG tablets, a product used for the treatment of neuropathic pain. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription drug product, with a total ceiling value of $4,162.48. The contract has a firm fixed price pricing type and is set to expire on September 19, 2024. This award is not associated with a set-aside program. Amerisourcebergen, through its Corporate...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,036.96 delivery order contract is for the supply of GRALISE ER 300 MG TABLET 90S, a prescription medication. The contract is a firm fixed price arrangement with a completion date of November 24, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,409.34 firm fixed-price delivery order is for the supply of GRALISE ER 600 MG TABLET 90S, a medication. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,285.30 Firm Fixed Price delivery order is for the supply of GRALISE ER 300 MG tablets, with a completion date of July 11, 2024. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,189.30, is a firm fixed-price delivery order for the provision of 4564931397 GRALISE ER 300 MG TABLET 90S. The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,802.81, is for the delivery of GRALISE ER 300 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...